Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 319-333
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.319
Table 1 Comparison of general information between the two groups of patients, n (%)

Experimental group (n = 27)
Control group (n = 28)
P value
Mean age (range, yr)52 (44-60)51 (40-62)0.516
Gender
Male19 (70.4)21 (75)0.70
Female8 (29.6)7 (25)
Years of education
< 98 (29.6)9 (32.2)0.747
9-1215 (55.6)13 (46.4)
> 124 (14.8)6 (21.4)
Marital status
Married20 (74.1)24 (85.7)0.555
Unmarried2 (7.4)1 (3.6)
Divorced5 (18.5)3 (10.7)
Clinical stage
I3 (11.1)2 (7.2)0.763
II11 (40.8)10 (35.7)
III13 (48.1)16 (57.1)
Chemotherapy
XELOX12 (44.4)10 (35.7)0.509
FOLOX15 (55.6)18 (64.3)
Mean BMI (kg/m2)22.56 (20.38-24.05)22.71 (21.22-24.19)0.561
Mean MMSE score24 (22-27)24 (22-27)0.765